Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
Conclusions:
In the AFNET registry, anticoagulation for secondary stroke prevention was prescribed in roughly three-quarters of AF patients, a significantly higher rate than in primary prevention. We identified two factors associated with withholding oral anticoagulation in stroke survivors, namely higher age and—most prominently—treatment by a general practitioner/internist or physicians working at regional hospitals.
Source: BMC Neurology - Category: Neurology Authors: Karl HaeuslerAndrea GerthTobias LimbourgUlrich TebbeMichael OeffKarl WegscheiderAndrás TreszlUrsula RavensThomas MeinertzPaulus KirchhofGünter BreithardtGerhard SteinbeckMichael Nabaueron behalf of the AFNET registry investigators Source Type: research
More News: Atrial Fibrillation | Brain | Cardiology | Cardiovascular | Heart | Hospital Management | Ischemic Stroke | Neurology | Primary Care | Stroke | Vitamin K | Vitamins